Literature DB >> 15908136

Predictors of disclosure of continued cocaine use.

Katherine Tassiopoulos1, Judith Bernstein, Timothy Heeren, Suzette Levenson, Ralph Hingson, Edward Bernstein.   

Abstract

Lack of disclosure of substance use is common in research and treatment settings and is frequently higher at follow-up than at baseline interviews. The aim of this study was to determine predictors of cocaine use disclosure at follow-up among 525 individuals who reported and tested positive for baseline use. Measurements included self-reported quantity and frequency of use, and hair analysis by radioimmune assay. Forty-two percent of individuals with biochemical evidence of continued cocaine use denied this use. In adjusted analyses, self-reported substance abuse treatment contact after enrollment was associated with lower disclosure (OR 0.63, 95% CI 0.43, 0.93). Other predictors were race, hair cocaine level, and opiates in hair. Failure to stop use after seeking treatment may result in reduced disclosure of continued use, possibly because of unwillingness to admit failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15908136     DOI: 10.1016/j.addbeh.2005.04.005

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  11 in total

1.  Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.

Authors:  Katherine Tassiopoulos; Jennifer S Read; Susan Brogly; Kenneth Rich; Barry Lester; Stephen A Spector; Ram Yogev; George R Seage
Journal:  AIDS Behav       Date:  2010-12

2.  Just say "I don't": lack of concordance between teen report and biological measures of drug use.

Authors:  Virginia Delaney-Black; Lisa M Chiodo; John H Hannigan; Mark K Greenwald; James Janisse; Grace Patterson; Marilyn A Huestis; Joel Ager; Robert J Sokol
Journal:  Pediatrics       Date:  2010-10-25       Impact factor: 7.124

3.  Inconsistencies in self-reported drug use by adolescents in substance abuse treatment: implications for outcome and performance measurements.

Authors:  Katherine M Harris; Beth Ann Griffin; Daniel F McCaffrey; Andrew R Morral
Journal:  J Subst Abuse Treat       Date:  2007-07-05

4.  Postmortem diagnosis and toxicological validation of illicit substance use.

Authors:  Elin Lehrmann; Zoan R Afanador; Amy Deep-Soboslay; Gloria Gallegos; William D Darwin; Ross H Lowe; Allan J Barnes; Marilyn A Huestis; Jean L Cadet; Mary M Herman; Thomas M Hyde; Joel E Kleinman; William J Freed
Journal:  Addict Biol       Date:  2008-01-14       Impact factor: 4.280

5.  The Community Substance Use Environment: The Development and Predictive Ability of a Multi-method and Multiple-reporter Measure.

Authors:  Sarah M Chilenski; Mark T Greenberg; Mark E Feinberg
Journal:  J Community Appl Soc Psychol       Date:  2010-01-01

6.  Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies.

Authors:  Megan S Schuler; William V Lechner; Rickey E Carter; Robert Malcolm
Journal:  J Addict Med       Date:  2009-12       Impact factor: 3.702

7.  The validity of drug use responses in a household survey in Puerto Rico: comparison of survey responses with urinalysis.

Authors:  H M Colón; C M Pérez; M Meléndez; E Marrero; A P Ortiz; E Suárez
Journal:  Addict Behav       Date:  2010-02-10       Impact factor: 3.913

8.  Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users.

Authors:  Kenzie L Preston; Michelle L Jobes; Karran A Phillips; David H Epstein
Journal:  Behav Pharmacol       Date:  2016-10       Impact factor: 2.293

9.  Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use.

Authors:  Jan Gryczynski; Robert P Schwartz; Shannon Gwin Mitchell; Kevin E O'Grady; Steven J Ondersma
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

10.  Assessment of explanatory models of mental illness: effects of patient and interviewer characteristics.

Authors:  Samrad Ghane; Annemarie M Kolk; Paul M G Emmelkamp
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-21       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.